Hepatic arterial infusion of autologous gamma/delta T cell for advanced hepatocellular carcinoma

Trial Profile

Hepatic arterial infusion of autologous gamma/delta T cell for advanced hepatocellular carcinoma

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Oct 2016

At a glance

  • Drugs T-lymphocyte cell therapy (Primary) ; Zoledronic acid
  • Indications Liver cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 29 Sep 2016 Status changed from active, no longer recruiting to completed.
    • 12 Jul 2016 Status changed from recruiting to active, no longer recruiting.
    • 20 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top